Cargando…
Identification of a Gut Commensal That Compromises the Blood Pressure-Lowering Effect of Ester Angiotensin-Converting Enzyme Inhibitors
BACKGROUND: Despite the availability of various classes of antihypertensive medications, a large proportion of hypertensive individuals remain resistant to treatments. The reason for what contributes to low efficacy of antihypertensive medications in these individuals is elusive. The knowledge that...
Autores principales: | Yang, Tao, Mei, Xue, Tackie-Yarboi, Ethel, Akere, Millicent Tambari, Kyoung, Jun, Mell, Blair, Yeo, Ji-Youn, Cheng, Xi, Zubcevic, Jasenka, Richards, Elaine M., Pepine, Carl J., Raizada, Mohan K., Schiefer, Isaac T., Joe, Bina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278702/ https://www.ncbi.nlm.nih.gov/pubmed/35538603 http://dx.doi.org/10.1161/HYPERTENSIONAHA.121.18711 |
Ejemplares similares
-
Ain’t No Sunshine When They’re Gone: Rendering the Gut Microbiota “Homeless” by Cecectomy Reveals Their True Thermogenic Potential
por: Zubcevic, Jasenka, et al.
Publicado: (2021) -
Angiotensin-(1-7)/Angiotensin-Converting Enzyme 2/Mas Receptor Axis and Related Mechanisms
por: Ferreira, Anderson J., et al.
Publicado: (2012) -
Reply to “Angiotensin-converting enzyme 2, sex differences, and COVID-19: The missing link”
por: Elgendy, Islam Y., et al.
Publicado: (2021) -
Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases
por: Sharma, Ravindra K., et al.
Publicado: (2021) -
Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Receptor Axis: Emerging Pharmacological Target for Pulmonary Diseases
por: Shenoy, Vinayak, et al.
Publicado: (2015)